Ameritas Investment Partners
NVCR icon

Ameritas Investment Partners’s NovoCure NVCR Stock Holding History

Ameritas Investment Partners’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$147K Buy
9,708
+1,219
+14% +$18.4K ﹤0.01% 1597
2026
Q1 		$92.5K Hold
8,489
– – ﹤0.01% 1736
2025
Q4 		$110K Hold
8,489
– – ﹤0.01% 1637
2025
Q3 		$110K Sell
8,489
-1,885
-18% -$25.2K ﹤0.01% 1632
2025
Q2 		$185K Sell
10,374
-767
-7% -$13.4K 0.01% 1338
2025
Q1 		$199K Hold
11,141
– – 0.01% 1268
2024
Q4 		$332K Buy
11,141
+708
+7% +$15K 0.01% 1026
2024
Q3 		$163K Hold
10,433
– – 0.01% 1456
2024
Q2 		$179K Buy
+10,433
New +$183K 0.01% 1349
2020
Q2 		– Sell
-7,610
Closed -$512K – 3114
2020
Q1 		$512K Buy
7,610
+187
+3% +$14.8K 0.03% 615
2019
Q4 		$626K Buy
7,423
+199
+3% +$16.1K 0.03% 689
2019
Q3 		$540K Sell
7,224
-10
-0.1% -$800 0.02% 721
2019
Q2 		$457K Buy
7,234
+1,201
+20% +$60.9K 0.02% 759
2019
Q1 		$291K Hold
6,033
– – 0.01% 873
2018
Q4 		$202K Hold
6,033
– – 0.01% 954
2018
Q3 		$316K Hold
6,033
– – 0.01% 856
2018
Q2 		$189K Buy
6,033
+963
+19% +$26.8K 0.01% 1097
2018
Q1 		$111K Hold
5,070
– – 0.01% 1423
2017
Q4 		$102K Hold
5,070
– – ﹤0.01% 1493
2017
Q3 		$103K Hold
5,070
– – ﹤0.01% 1442
2017
Q2 		$88K Buy
5,070
+1,123
+28% +$14.5K ﹤0.01% 1539
2017
Q1 		$32K Buy
+3,947
New +$28.5K ﹤0.01% 2124

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Ameritas Investment Partners's NVCR Position: Q2 2026 in Review

Ameritas Investment Partners increased its NovoCure (NVCR) stake by 14% in Q2 2026, buying an estimated $18.4K and bringing the position to 9,708 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1597.

Ameritas Investment Partners first reported a position in NVCR in Q1 2017 and has held it in 22 quarters since. The position peaked at $626K in Q4 2019. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Ameritas Investment Partners held 9,708 shares of NovoCure worth $147K as of Q2 2026.
  • Ameritas Investment Partners bought 1,219 NovoCure shares in Q2 2026, an estimated $18.4K.
  • NovoCure made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1597 holding.
  • Ameritas Investment Partners first reported a position in NovoCure in Q1 2017 and has held it in 22 quarters since.
  • Ameritas Investment Partners's NovoCure position peaked at $626K in Q4 2019.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.